Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-16

Clinical Trial Update: Gabapentin Versus Loratadine in Uremic Pruritus [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing gabapentin to loratadine for uremic pruritus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Loratadine (Loratadine)

Snippet

Sponsor: King Edward Medical University | Conditions: Pruritus, Uremia | Phase 4 | Status: COMPLETED